Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease-More thought is needed-Authors' reply

Aliment Pharmacol Ther. 2023 Oct;58(8):840-841. doi: 10.1111/apt.17696.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents* / adverse effects
  • Dysbiosis
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy

Substances

  • Anti-Bacterial Agents